Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Dec 2020

El Hussein Siba, Shaw Kenna R M, Vega Francisco

Abstract excerpt

Recently, comprehensive genomic analyses have allowed a better molecular characterization of diffuse large B-cell lymphoma (DLBCL), offering novel opportunities in patient risk stratification and management. In the era of precision medicine, this has allowed us to move closer toward a more promising therapeutic outcome in the setting of DLBCL. In this review, we highlight the newly reported heterogeneous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Heterogeneity

Share to Immunotherapy

Share to Lymphoma, Large B-Cell, Diffuse

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Tumor Microenvironment

Source

Identifiers

PMID: 32620919
DOI: 10.1038/s41379-020-0616-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.PMID 32620919Read ↗

The genetic landscape of diffuse large B-cell lymphoma.Semantic proximity Read ↗

The genetic basis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications.Semantic proximity Read ↗

Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor MicroenvironmentSemantic proximity Read ↗

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Semantic proximity Read ↗

Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Genetics of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSemantic proximity Read ↗

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.Semantic proximity Read ↗

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Semantic proximity Read ↗

Genetic heterogeneity of diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.